drugset / Trial / NCT03792321

Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)

NCT03792321

Phase 4 Completed 55 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupDouble-blindTreatment

Summary

Aim of the study was to investigate the effects of testosterone replacement therapy on components of metabolic syndrome, vascular function and morphology, grade of non-alcoholic fatty liver disease (NAFLD), bone mineral density (BMD) and health-related quality of life.

Timeline

Start
2014-01-10
Primary completion
2015-03-05
Completion
2018-03-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Undecanoate Small molecule 1000 mg Intramuscular